Sakar Healthcare profit and loss

·UnclassifiedChart ›

Latest FY26

Revenue: ₹252cr+41.8% on FY25
EBITDA: ₹68.9cr+38.7% on FY25
Net profit: ₹30.5cr+74.2% on FY25
EPS: ₹13.70+71.9% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	302	252	178	153	133	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2.5	2.3	1.3	3.2	4.7
	304	254	179	157	138
	163	133	95.5	85.1	73.9
	−19.2	−9.4	−13.2	−1.4	−0.4
	44.0	38.7	31.6	19.8	16.8
	7.9	7.9	8.5	7.6	5.9
	25.5	23.6	20.9	18.1	15.0
	23.1	20.9	14.0	11.5	9.9
	245	214	157	141	121
	90.4	68.9	49.7	38.4	33.1
	65.0	45.3	28.8	20.3	18.2
Profit
	59.6	39.8	21.6	15.9	16.9
	0.0	0.0	−0.1	0.0	−0.0
	59.6	39.8	21.5	15.9	16.9
	14.2	6.2	0.0	0.0	2.9
	2.6	3.0	4.0	4.2	1.2
	16.7	9.3	4.0	4.2	4.1
	42.9	30.5	17.5	11.7	12.8
	42.9	30.5	17.5	11.7	12.8
	−0.1	−0.1	−0.1	−0.1	−0.2
	42.8	30.4	17.4	11.6	12.5
	—	30.5	—	—	—
Per share
	₹19.25	₹13.70	₹7.97	₹5.64	₹6.59
	₹19.25	₹13.70	₹7.95	₹5.63	₹6.59
Other comprehensive income — detail
	−0.1	−0.1	−0.1	—	—
	−0.1	−0.1	−0.2	−0.1	−0.3
	−0.0	−0.0	−0.0	—	—
	—	—	—	−0.0	−0.1
	—	30.4	—	11.6	12.5
Per share — as-filed variants
	₹19.25	₹13.70	₹7.97	₹5.64	₹6.59
	₹19.25	₹13.70	₹7.95	₹5.63	₹6.59
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	158	128	95.3	69.7	59.8
	52.2%	51.0%	53.7%	45.4%	44.9%
Adjusted (ex-exceptional items) — derived
	59.6	39.8	21.6	15.9	16.9
	0.0	0.0	−0.1	0.0	−0.0
	42.9	30.5	17.5	11.7	12.8
	₹19.25	₹13.70	₹7.99	₹5.64	₹6.59

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified

Annual Quarterly₹ CrorePeersMACPOWER SERVOTECH KAPSTON THEJOBETAMcap ₹2,106 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	133.4	153.4	177.6	251.7	301.8
Other Income	4.7	3.2	1.3	2.3	2.5
Total Income	138.0	156.5	178.9	254.0	304.3
Expenses
+ Cost of Materials Consumed	73.9	85.1	95.5	132.7	163.4
+ Changes in Inventories	-0.4	-1.4	-13.2	-9.4	-19.2
+ Employee Benefit Expense	16.8	19.8	31.6	38.7	44.0
+ Finance Costs	5.9	7.6	8.5	7.9	7.9
+ Depreciation & Amortisation	15.0	18.1	20.9	23.6	25.5
+ Other Expenses	9.9	11.5	14.0	20.9	23.1
Total Expenses	121.2	140.6	157.3	214.3	244.7
EBITDA	33.1	38.4	49.7	68.9	90.4
EBIT	18.2	20.3	28.8	45.3	65.0
Profit
PBT before Exceptional Items	16.9	15.9	21.6	39.8	59.6
+ Exceptional Items	-0.0	0.0	-0.1	0.0	0.0
Pretax Income	16.9	15.9	21.5	39.8	59.6
+ Current Tax	2.9	0.0	0.0	6.2	14.2
+ Deferred Tax	1.2	4.2	4.0	3.0	2.6
Tax Expense	4.1	4.2	4.0	9.3	16.7
Net Income	12.8	11.7	17.5	30.5	42.9
+ Net Income — Continuing Ops	12.8	11.7	17.5	30.5	42.9
+ Other Comprehensive Income	-0.2	-0.1	-0.1	-0.1	-0.1
Total Comprehensive Income	12.5	11.6	17.4	30.4	42.8
Net Income to Common	—	—	—	30.5	—
Per Share
Basic EPS	6.59	5.64	7.97	13.70	19.25
Diluted EPS	6.59	5.63	7.95	13.70	19.25
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	-0.1	-0.1
+ Items NOT to be Reclassified to P&L	-0.3	-0.1	-0.2	-0.1	-0.1
+ Tax on Items NOT to be Reclassified	—	—	-0.0	-0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	-0.0	—	—	—
Comprehensive Income — Owners of Parent	12.5	11.6	—	30.4	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	6.59	5.64	7.97	13.70	19.25
Diluted EPS — Continuing Operations	6.59	5.63	7.95	13.70	19.25
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	59.8	69.7	95.3	128.5	157.6
Gross Margin %	44.85	45.43	53.68	51.03	52.21
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	16.9	15.9	21.6	39.8	59.6
− Exceptional Items (reconciliation)	-0.0	0.0	-0.1	0.0	0.0
Net Income Adj (tax-effected)	12.8	11.7	17.5	30.5	42.9
EPS Adj	6.59	5.64	7.99	13.70	19.25
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	19.0	21.7	21.9	22.2	22.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.